Latest news with #CboeCanada
Globe and Mail
26-05-2025
- Business
- Globe and Mail
Vanguard Announces Cash Distributions for the Vanguard ETFs
TORONTO, May 26, 2025 (GLOBE NEWSWIRE) -- Vanguard Investments Canada Inc. today announced the final May 2025 cash distributions for certain Vanguard ETFs, listed below, that trade on Cboe Canada and the Toronto Stock Exchange (TSX). Unitholders of record on June 02, 2025 will receive cash distributions payable on June 09, 2025. Details of the 'per unit' distribution amounts are as follows: Vanguard ETF ® Cboe Ticker Symbol Distribution per Unit ($) CUSIP ISIN Payment Frequency Vanguard U.S. Aggregate Bond Index ETF (CAD-hedged) VBU 0.056811 92206G103 CA92206G1037 Monthly Vanguard Global ex-U.S. Aggregate Bond Index ETF (CAD-hedged) VBG 0.038139 92206H101 CA92206H1010 Monthly Vanguard Global Aggregate Bond Index ETF (CAD-hedged) VGAB 0.044673 92211F108 CA92211F1080 Monthly To learn more about the Cboe Canada Exchange-listed Vanguard ETFs, please visit Vanguard ETF ® TSX Ticker Symbol Distribution per Unit ($) CUSIP ISIN Payment Frequency Vanguard Canadian Aggregate Bond Index ETF VAB 0.063108 92203E101 CA92203E1016 Monthly Vanguard Canadian Short-Term Bond Index ETF VSB 0.064594 92203G106 CA92203G1063 Monthly Vanguard Canadian Short-Term Corporate Bond Index ETF VSC 0.072412 92203N101 CA92203N1015 Monthly Vanguard Canadian Corporate Bond Index ETF VCB 0.079517 92210P107 CA92210P1071 Monthly Vanguard Canadian Government Bond Index ETF VGV 0.056731 92210N102 CA92210N1024 Monthly Vanguard Canadian Long-Term Bond Index ETF VLB 0.066496 92211H104 CA92211H1047 Monthly Vanguard Canadian Ultra-Short Government Bond Index ETF VVSG 0.105996 92213B105 CA92213B1058 Monthly Vanguard FTSE Canadian Capped REIT Index ETF VRE 0.076359 92203B107 CA92203B1076 Monthly Vanguard FTSE Canadian High Dividend Yield Index ETF VDY 0.228109 92203Q104 CA92203Q1046 Monthly Vanguard Retirement Income ETF Portfolio VRIF 0.083000 92211X109 CA92211X1096 Monthly To learn more about the TSX-listed Vanguard ETFs, please visit About Vanguard Canadians own CAD $132 billion in Vanguard assets, including Canadian and U.S.-domiciled ETFs and Canadian mutual funds. Vanguard Investments Canada Inc. manages CAD $96 billion in assets (as of April 30, 2025) with 38 Canadian ETFs and ten mutual funds currently available. The Vanguard Group, Inc. is one of the world's largest investment management companies and a leading provider of company-sponsored retirement plan services. Vanguard manages USD $10 trillion (CAD $13.7 trillion) in global assets, including over USD $3.3 trillion (CAD $4.5 trillion) in global ETF assets (as of April 30, 2025). Vanguard has offices in the United States, Canada, Mexico, Europe and Australia. The firm offers 441 funds, including ETFs, to its more than 50 million investors worldwide. Vanguard operates under a unique operating structure. Unlike firms that are publicly held or owned by a small group of individuals, The Vanguard Group, Inc. is owned by Vanguard's U.S.-domiciled funds and ETFs. Those funds, in turn, are owned by Vanguard clients. This unique mutual structure aligns Vanguard interests with those of its investors and drives the culture, philosophy, and policies throughout the Vanguard organization worldwide. As a result, Canadian investors benefit from Vanguard's stability and experience, low-cost investing, and client focus. For more information, please visit For more information, please contact: Matt Gierasimczuk Vanguard Canada Public Relations Phone: 416-263-7087 matthew_gierasimczuk@ Important information Commissions, management fees, and expenses all may be associated with investment funds. Investment objectives, risks, fees, expenses, and other important information are contained in the prospectus; please read it before investing. Investment funds are not guaranteed, their values change frequently, and past performance may not be repeated. Vanguard funds are managed by Vanguard Investments Canada Inc. and are available across Canada through registered dealers. London Stock Exchange Group companies include FTSE International Limited ("FTSE"), Frank Russell Company ("Russell"), MTS Next Limited ("MTS"), and FTSE TMX Global Debt Capital Markets Inc. ("FTSE TMX"). All rights reserved. "FTSE®", "Russell®", "MTS®", "FTSE TMX®" and "FTSE Russell" and other service marks and trademarks related to the FTSE or Russell indexes are trademarks of the London Stock Exchange Group companies and are used by FTSE, MTS, FTSE TMX and Russell under licence. All information is provided for information purposes only. No responsibility or liability can be accepted by the London Stock Exchange Group companies nor its licensors for any errors or for any loss from use of this publication. Neither the London Stock Exchange Group companies nor any of its licensors make any claim, prediction, warranty or representation whatsoever, expressly or impliedly, either as to the results to be obtained from the use of the FTSE Indexes or the fitness or suitability of the Indexes for any particular purpose to which they might be put. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ('SPDJI'), and has been licensed for use by The Vanguard Group, Inc. (Vanguard). Standard & Poor's®, S&P® and S&P 500® are registered trademarks of Standard & Poor's Financial Services LLC ('S&P'); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC ('Dow Jones'); and these trademarks have been licensed for use by SPDJI and sublicensed for certain purposes by Vanguard. Vanguard ETFs are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of the S&P 500 Index.
National Post
22-05-2025
- Business
- National Post
Onco-Innovations Uplists to Cboe Canada
Article content TORONTO — Cboe Canada Inc. ('Cboe Canada') is pleased to announce that Onco-Innovations Limited ('Onco'), a Canadian-based company dedicated to cancer research and treatment, has uplisted to Cboe Canada and is available for trading under the ticker symbol ONCO. Article content Article content Onco has a core mission to prevent and cure cancer through cutting edge science. The company holds an exclusive global license to patented technology targeting solid tumors — and is now expanding into AI-driven analytics for multimodal real-world data. Article content 'Onco-Innovations is at a pivotal stage,' said Thomas O'Shaughnessy, CEO of Onco. 'Our growth now extends beyond drug development into AI-powered research, with a view to creating faster, smarter pathways to new cancer therapies. This convergence of science and technology positions Onco as a next-generation oncology company ready to tackle some of the biggest challenges in the field.' Article content 'Joining Cboe is more than a listing — it's a strategic alignment,' added O'Shaughnessy. 'It gives us the tools to deepen investor engagement, expand our network, and accelerate our journey toward transforming the future of cancer therapy.' Article content Cboe Canada's commitment to supporting innovative, high-growth companies and delivering global reach makes it a natural partner for Onco's ambitious vision. Article content 'It is an honour to welcome Onco to the growing roster of Cboe Listed issuers,' remarked Tanya Rowntree, Head of Listings at Cboe Canada. 'Their move to a Tier 1 listing on Cboe reflects both their strategic growth trajectory and the confidence in our platform to support next-generation innovators. Onco now benefits from enhanced access to capital, greater liquidity, and increased visibility among investors and institutions alike.' Article content Investors can trade shares of ONCO through their usual investment channels, including discount brokerages and full-service dealers. To explore all listed securities on Cboe Canada, click here. Article content Cboe Canada is home to some of the most innovative Canadian and international growth companies, ETFs from Canada's largest ETF issuers, and more than 120 Canadian Depositary Receipts (CDRs). Cboe consistently facilitates 15% of all volume traded in Canadian listed securities. Article content About Cboe Canada Article content Cboe Canada is Canada's Tier 1 stock exchange providing a best-in-class listing experience for issuers that are shaping the economies of tomorrow. Fully operational since 2015, Cboe Canada lists companies and investment products seeking a robust and internationally recognized platform that enables investor trust, quality liquidity, and broad awareness including unfettered access to market data. Article content Cboe Canada is part of Cboe Global Markets, the leading securities and derivatives exchange for the world stage. With exchanges in North America, Europe and Asia Pacific, Cboe is harnessing its global network to equip Issuers with essential capital markets solutions. Article content Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to prevent and cure cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide license to patented technology that targets solid tumours, setting new standards in cancer treatment. Onco is focused on advancing personalized therapies that improve cancer outcomes and set new standards in oncology research. Article content Article content Article content Article content Article content
Business Wire
22-05-2025
- Business
- Business Wire
Onco-Innovations Uplists to Cboe Canada
TORONTO--(BUSINESS WIRE)-- Cboe Canada Inc. ('Cboe Canada') is pleased to announce that Onco-Innovations Limited ('Onco'), a Canadian-based company dedicated to cancer research and treatment, has uplisted to Cboe Canada and is available for trading under the ticker symbol ONCO. Onco has a core mission to prevent and cure cancer through cutting edge science. The company holds an exclusive global license to patented technology targeting solid tumors — and is now expanding into AI-driven analytics for multimodal real-world data. 'Onco-Innovations is at a pivotal stage,' said Thomas O'Shaughnessy, CEO of Onco. 'Our growth now extends beyond drug development into AI-powered research, with a view to creating faster, smarter pathways to new cancer therapies. This convergence of science and technology positions Onco as a next-generation oncology company ready to tackle some of the biggest challenges in the field.' 'Joining Cboe is more than a listing — it's a strategic alignment,' added O'Shaughnessy. 'It gives us the tools to deepen investor engagement, expand our network, and accelerate our journey toward transforming the future of cancer therapy.' Cboe Canada's commitment to supporting innovative, high-growth companies and delivering global reach makes it a natural partner for Onco's ambitious vision. 'It is an honour to welcome Onco to the growing roster of Cboe Listed issuers,' remarked Tanya Rowntree, Head of Listings at Cboe Canada. 'Their move to a Tier 1 listing on Cboe reflects both their strategic growth trajectory and the confidence in our platform to support next-generation innovators. Onco now benefits from enhanced access to capital, greater liquidity, and increased visibility among investors and institutions alike.' Investors can trade shares of ONCO through their usual investment channels, including discount brokerages and full-service dealers. To explore all listed securities on Cboe Canada, click here. Cboe Canada is home to some of the most innovative Canadian and international growth companies, ETFs from Canada's largest ETF issuers, and more than 120 Canadian Depositary Receipts (CDRs). Cboe consistently facilitates 15% of all volume traded in Canadian listed securities. About Cboe Canada Cboe Canada is Canada's Tier 1 stock exchange providing a best-in-class listing experience for issuers that are shaping the economies of tomorrow. Fully operational since 2015, Cboe Canada lists companies and investment products seeking a robust and internationally recognized platform that enables investor trust, quality liquidity, and broad awareness including unfettered access to market data. Cboe Canada is part of Cboe Global Markets, the leading securities and derivatives exchange for the world stage. With exchanges in North America, Europe and Asia Pacific, Cboe is harnessing its global network to equip Issuers with essential capital markets solutions. About Onco-Innovations Limited Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to prevent and cure cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide license to patented technology that targets solid tumours, setting new standards in cancer treatment. Onco is focused on advancing personalized therapies that improve cancer outcomes and set new standards in oncology research.
Yahoo
21-05-2025
- Business
- Yahoo
Fidelity Investments Canada ULC Announces Cash Distributions for Certain Fidelity ETFs and ETF Series of Fidelity Mutual Funds
TORONTO, May 21, 2025 /CNW/ - Fidelity Investments Canada ULC today announced the May 2025 cash distributions for the Fidelity ETFs ("Fidelity ETFs") and ETF Series of Fidelity mutual funds ("Fidelity Funds") listed below. For Fidelity ETFs, unitholders of record as of May 28, 2025, will receive a per-unit cash distribution payable on May 30, 2025, as detailed in the table below: Fidelity ETF Name Ticker Symbol Cash Distribution Per Unit (C$) CUSIP ISIN Payment Frequency Exchange Fidelity Canadian High Dividend ETF FCCD 0.09990 31608M102 CA31608M1023 Monthly Toronto Stock Exchange Fidelity U.S. High Dividend ETF FCUD/ FCUD.U 0.02022 31645M107 CA31645M1077 Monthly Toronto Stock Exchange Fidelity U.S. High Dividend Currency Neutral ETF FCUH 0.01642 315740100 CA3157401009 Monthly Toronto Stock Exchange Fidelity U.S. Dividend for Rising Rates ETF FCRR/ FCRR.U 0.02266 31644M108 CA31644M1086 Monthly Toronto Stock Exchange Fidelity International High Dividend ETF FCID 0.23839 31623D103 CA31623D1033 Monthly Toronto Stock Exchange Fidelity Systematic Canadian Bond Index ETF FCCB 0.06585 31644F103 CA31644F1036 Monthly Cboe Canada Fidelity Canadian Short Term Corporate Bond ETF FCSB 0.08205 31608N100 CA31608N1006 Monthly Cboe Canada Fidelity Global Core Plus Bond ETF FCGB/ FCGB.U 0.07949 31623G106 CA31623G1063 Monthly Cboe Canada Fidelity Canadian Monthly High Income ETF FCMI 0.04445 31609T106 CA31609T1066 Monthly Toronto Stock Exchange Fidelity Global Monthly High Income ETF FCGI 0.04814 31623K107 CA31623K1075 Monthly Toronto Stock Exchange Fidelity ETF Name Ticker Symbol Cash Distribution Per Unit (C$) CUSIP ISIN Payment Frequency Exchange Fidelity Global Investment Grade Bond ETF FCIG/ FCIG.U 0.07296 31624P105 CA31624P1053 Monthly Cboe Canada Fidelity Equity Premium Yield ETF FEPY/ FEPY.U 0.17030 31613F100 CA31613F1009 Monthly Cboe Canada Fidelity Core U.S. Bond ETF FCUB/ FCUB.U 0.08256 315945105 CA3159451051 Monthly Toronto Stock Exchange For ETF Series of Fidelity Funds, unitholders of record as of May 30, 2025 will receive a per-unit cash distribution payable on June 3, 2025, as detailed in the table below: Fidelity Fund Name Ticker Symbol Cash Distribution Per Unit (C$) CUSIP ISIN Payment Frequency Exchange Fidelity Tactical High Income Fund (ETF Series) FTHI 0.02824 31642L664 CA31642L6641 Monthly Toronto Stock Exchange Fidelity Absolute Income Fund (ETF Series) FCAB/ FCAB.U 0.10479 315944108 CA3159441086 Monthly Toronto Stock Exchange About Fidelity Investments Canada ULC At Fidelity Investments Canada, our mission is to build a better future for our clients. Our diversified business serves financial advisors, wealth management firms, employers, institutions and individuals. As the marketplace evolves, we are constantly innovating and offering our clients choice of investment and wealth management products, services and technological solutions all backed by the global strength and scale of Fidelity. With assets under management of $294 billion (as at May 20, 2025), Fidelity Investments Canada is privately held and committed to helping our diverse clients meet their goals over the long term. Fidelity funds are available through financial advisors and online trading platforms. Read a fund's prospectus and consult your financial advisor before investing. Exchange-traded funds are not guaranteed; their values change frequently and past performance may not be repeated. Commissions, management fees, brokerage fees and expenses may all be associated with investments in exchange-traded funds and investors may experience a gain or loss. Find us on social media @FidelityCanada Listen to FidelityConnects on Apple or Spotify 2658681-v2025521 SOURCE Fidelity Investments Canada ULC View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Globe and Mail
20-05-2025
- Business
- Globe and Mail
Scotia Global Asset Management announces May 2025 cash distributions for Scotia ETFs
TORONTO, May 20, 2025 /CNW/ - Scotia Global Asset Management announced today the May 2025 cash distributions for the Scotia ETFs listed on the Cboe Canada exchange, which pay on a monthly basis. Unitholders of record on May 27, 2025 will receive a cash distribution payable on June 3, 2025, as noted below.
